Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, June 1998, p. 1361-1364, Vol. 42, No. 6
Departments of
Otolaryngology1 and
Medical
Microbiology,
Received 7 October 1997/Returned for modification 12 February
1998/Accepted 24 March 1998
The comparative efficacies of amoxicillin and cefuroxime against
acute otitis media caused by a penicillin-resistant (MIC, 2 µg/ml) Streptococcus pneumoniae strain were assessed in a
gerbil model by challenging each ear with 107 bacteria
through transbullar instillation. Each antibiotic was tested at two
doses (5 and 20 mg/kg of body weight) administered at 2, 10, and
18 h postinoculation. Samples were obtained from the middle ear
(ME) on days 3 and 7 postinoculation for determination of bacterial
counts. Only amoxicillin, at both doses, was able to significantly halt
the weight loss in animals, reducing both the number of
culture-positive animals and the bacterial concentration in ME samples
versus the values for untreated animals. Comparison of the efficacies
between the antibiotics, determined by their ability to achieve
culture-negative ME specimens, showed that amoxicillin at 5 mg/kg
was significantly more active than cefuroxime at the same dose. The use
of higher doses of either amoxicillin or cefuroxime did not
produce significantly better results than those obtained with
the lower dose but caused a greater inflammatory response. The
more favorable results obtained with amoxicillin compared with
those obtained with cefuroxime could be related to the antimicrobial
susceptibility of the pneumococcal strain (MICs and minimum
bactericidal concentrations of 1 and 1 µg/ml and 4 and 4 µg/ml
for amoxicillin and cefuroxime, respectively) as
well as to the better pharmacokinetic parameters obtained with amoxicillin.
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
In Vivo Efficacies of Amoxicillin and Cefuroxime
against Penicillin-Resistant Streptococcus pneumoniae in
a Gerbil Model of Acute Otitis Media
*
Corresponding author. Mailing address: Department of
Medical Microbiology, Fundación Jiménez Díaz,
Avenida de Reyes Católicos 2, 28040 Madrid, Spain. Phone:
34-1-544.73.87. Fax: 34-1-549.47.64. E-mail:
fsoriano{at}microb.net.
Antimicrobial Agents and Chemotherapy, June 1998, p. 1361-1364, Vol. 42, No. 6
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»